Hyperfunctioning parathyroid gland and skeletal involvement on [18F]fluorocholine PET/CT: one look with two views

European Journal of Hybrid Imaging - Tập 6 - Trang 1-8 - 2022
Carmela Nappi1, Leandra Piscopo1, Michele Klain1, Ciro Gabriele Mainolfi1, Emilia Vergara1, Daniela Adamo2, Michele Davide Mignogna2, Alberto Cuocolo1
1Department of Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy
2Department of Neuroscience, Reproductive Sciences, and Dentistry, University of Naples Federico II, Napoli, Italy

Tóm tắt

Hyperparathyroidism is an endocrine disorder that may be associated with other metabolic diseases. Non-invasive imaging techniques including [99mTc]Tc-sestamibi single-photon emission computed tomography (SPECT) and [18F]fluorocholine positron emission tomography (PET)/computed tomography (CT) play a key role on management of patients with hyperparathyroidism. We report for the first time a case of a patient with evidence of both hyperfunctioning parathyroid tissue and multiple lytic bone lesions on [18F]fluorocholine PET/CT imaging. The present case report highlights the potential role of whole-body [18F]fluorocholine PET/CT for the identification of both parathyroid adenoma and multiple bone lesions in a single diagnostic setting.

Tài liệu tham khảo

Albright F, Butler AM, Hampton AO, Smith P (1937) Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med 216:727–746 Assante R, Zampella E, Nicolai E, Acampa W, Vergara E, Nappi C et al (2019) Incremental value of sestamibi SPECT/CT over dual-phase planar scintigraphy in patients with primary hyperparathyroidism and inconclusive ultrasound. Front Med (lausanne) 6:164 Beheshti M, Hehenwarter L, Paymani Z, Rendl G, Imamovic L, Rettenbacher R et al (2018) [18F]fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with [99mTc]Tc-MIBI or [99mTc]Tc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging 45(10):1762–1771 Broos WAM, Wondergem M, Knol RJJ, van der Zant FM (2019) Parathyroid imaging with [18F]fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study. EJNMMI Res 9(1):72 Chapurlat RD, Orcel P (2008) Fibrous dysplasia of bone and McCune–Albright syndrome. Best Pract Res Clin Rheumatol 22(1):55–69 Collins MT, Singer FR, Eugster E (2012) McCune–Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis 7(Suppl 1):S4 Dominguete PR, Meyer TN, Alves FA, Bittencourt WS (2008) Juvenile ossifying fibroma of the jaw. Br J Oral Maxillofac Surg 46(6):480–481 Dumitrescu CE, Collins MT (2008) McCune–Albright syndrome. Orphanet J Rare Dis 3:12 Evangelista L, Ravelli I, Magnani F, Iacobone M, Giraudo C, Camozzi V et al (2020) 18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature. Ann Nucl Med 34(9):601–619 Hartley I, Zhadina M, Collins MT, Boyce AM (2019) Fibrous dysplasia of bone and McCune–Albright syndrome: a bench to bedside review. Calcif Tissue Int 104(5):517–529 Hodolic M (2011) Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma. Radiol Oncol 45(1):17–21 Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A et al (2019) Best practice management guidelines for fibrous dysplasia/McCune–Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis 14(1):139 Katz-Brull R, Margalit R, Bendel P, Degani H (1998) Choline metabolism in breast cancer; 2H-, 13C- and 31P-NMR studies of cells and tumors. MAGMA 6(1):44–52 Mazabraud A, Semat P (1967) Roze R (1967) Apropos of the association of fibromyxomas of the soft tissues with fibrous dysplasia of the bones. Presse Med (1893) 75(44):2223–2228 McCune DJ (1936) Osteitis fibrosa cystica; the case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 52:743–744 Nappi C, Megna R, Volpe F, Ponsiglione A, Caiazzo E, Piscopo L (2022) Quantification of coronary artery atherosclerotic burden and muscle mass: exploratory comparison of two freely available software programs. Appl Sci 12(11):5468 Petranović Ovčariček P, Giovanella L, Carrió Gasset I, Hindié E, Huellner MW, Luster M et al (2021) The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging 48(9):2801–2822 Schillaci O, Calabria F, Tavolozza M, Cicciò C, Carlani M, Caracciolo CR et al (2010) 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl Med Commun 31(1):39–45 Turcu AF, Clarke BL (2013) Fibrous dysplasia of bone associated with primary hyperparathyroidism. Endocr Pract 19(2):226–230 Weinstein LS (2006) G(s)alpha mutations in fibrous dysplasia and McCune–Albright syndrome. J Bone Miner Res 21(Suppl 2):P120–P124 Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N Engl J Med 325(24):1688–1695 Younes NA, Shafagoj Y, Khatib F, Ababneh M (2005) Laboratory screening for hyperparathyroidism. Clin Chim Acta 353(1–2):1–12 Zeisel SH (1981) Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr 1:95–121 Zhang R, Zhang Z, Huang P, Li Z, Hu R, Zhang J et al (2020) Diagnostic performance of ultrasonography, dual-phase [99mTc]Tc-MIBI scintigraphy, early and delayed [99mTc]Tc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism. BMC Med Imaging 20(1):91